Ultram and Gallbladder polyp - a phase IV clinical study of FDA data

Summary:

Gallbladder polyp is reported as a side effect among people who take Ultram (tramadol hydrochloride), especially for people who are female, 50-59 old, also take Cimetidine, and have Breast cancer.

The phase IV clinical study analyzes which people have Gallbladder polyp when taking Ultram. It is created by eHealthMe based on reports of 26,802 people who have side effects when taking Ultram from the FDA, and is updated regularly.

What is Ultram?

Ultram has active ingredients of tramadol hydrochloride. It is often used in pain. eHealthMe is studying from 28,425 Ultram users. Check the latest studies of Ultram.

What is Gallbladder polyp?

Gallbladder polyp (growths or lesions resembling growths (polypoid lesions) in the wall of the gallbladder) is found to be associated with 224 drugs and 305 conditions by eHealthMe. Check the latest studies of Gallbladder polyp.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 16, 2026

26,802 people reported to have side effects when taking Ultram.
Among them, 13 people (0.05%) have Gallbladder polyp.

Among these 13 people:

What is the gender of people who have Gallbladder polyp when taking Ultram? *

female: 100 %
male: 0.0 %

What is the age of people who have Gallbladder polyp when taking Ultram? *

What are other drugs people take besides Ultram? *

What are other side effects people have besides Gallbladder polyp? *

Nausea (feeling of having an urge to vomit): 12 people, 92.31%
Weakness: 12 people, 92.31%
Oedema Peripheral (superficial swelling): 12 people, 92.31%
Joint Pain: 12 people, 92.31%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 12 people, 92.31%
Pain In Extremity: 12 people, 92.31%
Hepatic Cyst: 11 people, 84.62%
Gait Disturbance: 11 people, 84.62%
Gastric Ulcer (stomach ulcer): 11 people, 84.62%
Gingival Bleeding (bleeding gums): 11 people, 84.62%

What are the existing conditions these people have? *

Ovarian Cancer (cancer of ovary): 11 people, 84.62%
Neoplasm Malignant (cancer tumour): 11 people, 84.62%
Migraine (headache): 11 people, 84.62%
Hot Flush (sudden feelings of heat): 11 people, 84.62%
Discomfort: 11 people, 84.62%
Breast Cancer Metastatic: 11 people, 84.62%
Breast Cancer: 11 people, 84.62%
Granulocyte Count Decreased: 10 people, 76.92%
Premenstrual Syndrome: 1 person, 7.69%
Birth Control: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Ultram and have Gallbladder polyp?

- Check whether Gallbladder polyp is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultram:

Ultram (28,425 reports)

Browse all side effects of Ultram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Gallbladder polyp:

Gallbladder polyp (224 drugs)

Browse all the conditions that are associated with Gallbladder polyp:

Gallbladder polyp (305 conditions)

Related publications that referenced our studies

Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .
Mansour HM, "Tramadol and Disseminated Intravascular Coagulopathy: A Case Report", Medicine Science, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on tramadol hydrochloride (the active ingredients of Ultram) and Ultram (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.